NEW YORK (GenomeWeb) — PositiveID and Ensco have been awarded a SenseNet Program contract for an undisclosed amount from the US Department of the Interior on behalf of the US Department of Homeland Security Science and Technology Directorate, Positive ID said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.